CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade

Authors

Yuji Sato, Washington University School of Medicine in St. Louis
Jennifer K Bolzenius, Washington University School of Medicine in St. Louis
Abdallah M Eteleeb, Washington University School of Medicine in St. Louis
Xinming Su, Washington University School of Medicine in St. Louis
Christopher A Maher, Washington University School of Medicine in St. Louis
Jennifer K Sehn, Washington University School of Medicine in St. Louis
Vivek K Arora, Washington University School of Medicine in St. Louis

Journal

JCI Insight

Publication Date

12-6-2018

Volume

3

Issue

23

First Page

e121062

Document Type

Open Access Publication

DOI

10.1172/jci.insight.121062

Rights and Permissions

Sato Y, Bolzenius JK, Eteleeb AM, Su X, Maher CA, Sehn JK, Arora VK. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018 Dec 6;3(23). e121062. doi: 10.1172/jci.insight.121062.

Recommended Citation

Sato, Yuji; Bolzenius, Jennifer K; Eteleeb, Abdallah M; Su, Xinming; Maher, Christopher A; Sehn, Jennifer K; and Arora, Vivek K, "CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade." JCI Insight. 3, 23. e121062 (2018).
https://digitalcommons.wustl.edu/open_access_pubs/9101